Article
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.
Current pharmaceutical design - 1 Jan 2016
Escargueil Alexandre E, Prado Soizic, Dezaire Ambre, Clairambault Jean, Larsen Annette K, Soares Daniele G
Abstract excerpt
Despite the efficacy of most cancer therapies, drug resistance remains a major problem in the clinic. The eradication of the entire tumor and the cure of the patient by chemotherapy alone are rare, in particular for advanced disease. From an evolutionary perspective, the selective pressure exerted by chemotherapy leads to the emergence of resistant clones where resistance can be associated with many different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
